ARCHIVES

NCI Tests Early Phase Study To Hasten Drug Development

This article is from The Cancer Letter archive.

Vol. 30 No. 8 | August 31, 2007

Download PDF Visit The Full Archive

Related Articles

Science Policy: Stem Cell Research Guidelines Formalize NIH Funding Polices

December 3, 1999

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

August 19, 1994

NCI Progress: Biomarker Labratories Funded To Develop Early Detection Methods

October 22, 1999

Consensus Growing On Prevention Strategies: Higginson

August 14, 1981

PDQ Needs Change, Advocates Say, NBCC to Build Its Own Trials Registry

October 11, 1996

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

January 8, 1999